Angina Market Report 2026

Angina Market Overview

• Angina market size has reached to $11.36 billion in 2025 • Expected to grow to $14.84 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: Rising Prevalence of Cardiovascular Diseases Driving The Market Growth Due To Increased Demand for Angina Treatments • Market Trend: Pharmaceutical Companies Innovate With Metoprolol Tartrate Tablets To Enhance Treatment For Coronary Artery Disease And Related Conditions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Angina Market?

Angina, also known as angina pectoris, is a medical condition characterized by chest pain or discomfort, typically caused by insufficient blood flow to the heart muscle. It inadequate blood flow is usually a result of blockages or narrowing of the coronary arteries due to atherosclerosis. The main types of angina are angina pectoris, unstable angina, prinzmetal angina, and others. Angina pectoris, a medical condition associated with coronary heart disease, manifests as chest discomfort or pain due to insufficient blood supply to the heart, often attributed to blockages in the heart's arteries. The different types of treatment include lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, others with various drug classes such as beta-blockers, nitrates, and calcium channel blockers, angiotensin-converting enzyme inhibitors, others that are used in multiple applications such as clinics, hospitals, and others.

What Is The Angina Market Growth Forecast?

The angina market size is expected to see strong growth in the next few years. It will grow to $14.84 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to growing demand for personalized cardiovascular treatment, increasing use of minimally invasive cardiac procedures, rising adoption of digital cardiac monitoring, expansion of preventive cardiology programs, advancements in cardiovascular drug development. Major trends in the forecast period include increasing adoption of combination drug therapies, rising use of long-acting nitrates, growing focus on preventive cardiac care, expansion of interventional treatment options, enhanced emphasis on lifestyle and risk management.

Global Angina Market Segmentation

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types 2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments 3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes 4) By Application: Clinics, Hospitals, Other Applications Subsegments: 1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina 2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina 3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina 4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

What Is The Driver Of The Angina Market?

The rising prevalence of cardiovascular diseases is expected to propel the growth of the angina market going forward. Cardiovascular diseases are disorders of the heart and blood vessels that include conditions such as coronary heart disease, heart failure, and stroke. The growing prevalence of cardiovascular diseases is largely driven by aging populations and increased exposure to modifiable risk factors such as poor diet, physical inactivity, and tobacco use. The rising prevalence of cardiovascular diseases boosts demand for angina treatments, as these conditions frequently manifest with chest pain requiring medical management to reduce symptoms and prevent complications. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency that monitors public health, cardiovascular disease deaths increased from 371,506 cases in 2022 to 919,032 deaths in 2023. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the angina industry.

Key Players In The Global Angina Market

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol‑Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Global Angina Market Trends and Insights

Major companies operating in the angina market are developing innovative drugs such as metoprolol tartrate tablets to provide more effective and targeted treatments for patients who have coronary artery disease (CAD) and related conditions. Metoprolol tartrate tablets are a form of medication commonly used to treat various cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, received final approval from the United States Food and Drug Administration (US-FDA) to manufacture and market its generic version of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol is a beta blocker used to treat various cardiovascular conditions, including high blood pressure (hypertension) and chest pain (angina), and to improve survival after a heart attack.

What Are Latest Mergers And Acquisitions In The Angina Market?

In March 2024, Novo Nordisk, a Denmark-based healthcare company, acquired Cardior Pharmaceuticals for $1.10 billion(€1.025 billion). This acquisition aims to strengthen Novo Nordisk's pipeline in cardiovascular disease management by incorporating Cardior's RNA-based therapeutics, particularly CDR132L, currently in Phase II clinical trials for treating heart failure. Cardior Pharmaceuticals is a Germany-based company that offers angiotensin-converting enzyme inhibitors.

Regional Outlook

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Angina Market?

The angina market consists of revenues earned by entities by providing treatments for stable angina, and microvascular angina. The market value includes the value of related goods sold by the service provider or included within the service offering. The angina market also includes sales of anticoagulants and statins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Angina Market Report 2026?

The angina market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the angina industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.